无质性贫血的医学治疗进展:为什么花了这么长时间?
1Division of Hematology, Hospital A Beneficência Portuguesa, Rua Martiniano de Carvalho, 951, São Paulo, SP, 01321-001, Brazil. scheinbp@bp.org.br.
International journal of hematology
|February 25, 2024
概括
无形成性贫血的治疗已经显著发展,现在的生存率超过80%. 免疫抑制疗法 (IST) 和eltrombopag的结合提供了最有效的医疗治疗严重无形成性贫血 (SAA).
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 在历史上,无形性贫血 (AA) 是致命的,但由于治疗的进步,存活率现在超过80-85%.
- 造血干细胞移植 (HSCT) 和免疫抑制疗法 (IST) 是主要的治疗方法,由于供体稀缺和患者因素,IST受到青.
- 反甲基球蛋白 (ATG) 和环素标志着AA管理的早期突破.
研究的目的:
- 审查过去50年来无塑性贫血治疗的演变.
- 突出关键的治疗里程碑和当前有效的治疗方案.
- 为了强调重症无形成性贫血 (SAA) 患者改善的结果.
主要方法:
- 对无塑性贫血的历史和当前治疗策略的审查.
- 分析各种治疗组合的疗效,包括IST和干细胞刺激.
- 专注于血栓形成素受体激活剂在现代AA管理中的作用.
主要成果:
- 最初仅加强IST的尝试不如预期那么成功.
- 将免疫抑制与干细胞刺激结合起来被证明比单独使用IST更有效.
- 目前对SAA最有效的医疗方案包括马抗细胞球蛋白 (马ATG),环素和eltrombopag.
结论:
- 无塑性贫血治疗的重大进展使其从致命疾病转变为可管理的疾病.
- IST与血栓形成素受体激动剂的结合代表了SAA治疗的重大进步.
- 目前的治疗方案为无形性贫血患者提供了显著改善的结果.
相关概念视频
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


